- Home
- SURG vs AKTX Comparison
SURG vs AKTX Comparison
Compare SURG & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- AKTX
- Stock Information
- Founded
- SURG 2006
- AKTX N/A
- Country
- SURG United States
- AKTX United States
- Employees
- SURG N/A
- AKTX N/A
- Industry
- SURG Advertising
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- SURG Consumer Discretionary
- AKTX Health Care
- Exchange
- SURG Nasdaq
- AKTX Nasdaq
- Market Cap
- SURG 27.0M
- AKTX 24.5M
- IPO Year
- SURG N/A
- AKTX N/A
- Fundamental
- Price
- SURG $1.79
- AKTX $1.27
- Analyst Decision
- SURG Strong Buy
- AKTX
- Analyst Count
- SURG 1
- AKTX 0
- Target Price
- SURG $8.50
- AKTX N/A
- AVG Volume (30 Days)
- SURG 4.5M
- AKTX 33.6K
- Earning Date
- SURG 03-25-2025
- AKTX 05-15-2025
- Dividend Yield
- SURG N/A
- AKTX N/A
- EPS Growth
- SURG N/A
- AKTX N/A
- EPS
- SURG N/A
- AKTX N/A
- Revenue
- SURG $60,881,173.00
- AKTX N/A
- Revenue This Year
- SURG $59.22
- AKTX N/A
- Revenue Next Year
- SURG $75.86
- AKTX N/A
- P/E Ratio
- SURG N/A
- AKTX N/A
- Revenue Growth
- SURG N/A
- AKTX N/A
- 52 Week Low
- SURG $1.05
- AKTX $0.85
- 52 Week High
- SURG $4.38
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- SURG 58.71
- AKTX 55.06
- Support Level
- SURG $1.29
- AKTX $1.26
- Resistance Level
- SURG $2.95
- AKTX $1.56
- Average True Range (ATR)
- SURG 0.21
- AKTX 0.13
- MACD
- SURG 0.10
- AKTX 0.02
- Stochastic Oscillator
- SURG 37.30
- AKTX 45.17
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).